
Cancer Research UK, Cytovation and the Norwegian Cancer Society collaborate to advance treatment for rare cancer
Collaboration to take Cytovation’s synthetic peptide, CY-101, into a Phase 2 trial for patients with adrenocortical carcinoma Cancer Research UK’s Centre for Drug Development to run the trial at sites in UK, and others across Europe The Norwegian Cancer …